Ran Ma is a biotech entrepreneur and pioneering researcher in precision medicine. As the founder and CEO of Sana Biotechnology, she is developing cutting-edge cell and gene therapies to treat a range of diseases.

With a PhD in genetics from MIT, Ma has authored groundbreaking papers in leading scientific journals. Her keynotes offer a glimpse into the future of personalized healthcare, sharing insights on how advancements in AI, genomics, and stem cell technology will transform medical treatment and improve patient outcomes.